These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma. Fassnacht M; Hahner S; Polat B; Koschker AC; Kenn W; Flentje M; Allolio B J Clin Endocrinol Metab; 2006 Nov; 91(11):4501-4. PubMed ID: 16895957 [TBL] [Abstract][Full Text] [Related]
6. Adrenocortical carcinoma in surgically treated patients: a retrospective study on 156 cases by the French Association of Endocrine Surgery. Icard P; Chapuis Y; Andreassian B; Bernard A; Proye C Surgery; 1992 Dec; 112(6):972-9; discussion 979-80. PubMed ID: 1455322 [TBL] [Abstract][Full Text] [Related]
7. [Surgical strategy in the treatment of adrenal cortex cancer. Expanded and repeated interventions]. Borrelli D; Bergamini C; Borrelli A; Reddavide S; Lassig R; Valeri A Ann Ital Chir; 2003; 74(3):311-7. PubMed ID: 14677288 [TBL] [Abstract][Full Text] [Related]
8. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. Luton JP; Cerdas S; Billaud L; Thomas G; Guilhaume B; Bertagna X; Laudat MH; Louvel A; Chapuis Y; Blondeau P N Engl J Med; 1990 Apr; 322(17):1195-201. PubMed ID: 2325710 [TBL] [Abstract][Full Text] [Related]
9. A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist. Abraham J; Bakke S; Rutt A; Meadows B; Merino M; Alexander R; Schrump D; Bartlett D; Choyke P; Robey R; Hung E; Steinberg SM; Bates S; Fojo T Cancer; 2002 May; 94(9):2333-43. PubMed ID: 12015757 [TBL] [Abstract][Full Text] [Related]
10. The long-term survival in adrenocortical carcinoma with active surgical management and use of monitored mitotane. Wängberg B; Khorram-Manesh A; Jansson S; Nilsson B; Nilsson O; Jakobsson CE; Lindstedt S; Odén A; Ahlman H Endocr Relat Cancer; 2010 Mar; 17(1):265-72. PubMed ID: 20026647 [TBL] [Abstract][Full Text] [Related]
11. Adjuvant radiation therapy improves local control after surgical resection in patients with localized adrenocortical carcinoma. Sabolch A; Else T; Griffith KA; Ben-Josef E; Williams A; Miller BS; Worden F; Hammer GD; Jolly S Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):252-9. PubMed ID: 25754631 [TBL] [Abstract][Full Text] [Related]
12. Surgical management, DNA content, and patient survival in adrenal cortical carcinoma. Lee JE; Berger DH; el-Naggar AK; Hickey RC; Vassilopoulou-Sellin R; Gagel RF; Burgess MA; Evans DB Surgery; 1995 Dec; 118(6):1090-8. PubMed ID: 7491528 [TBL] [Abstract][Full Text] [Related]
13. Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers. Fassnacht M; Johanssen S; Fenske W; Weismann D; Agha A; Beuschlein F; Führer D; Jurowich C; Quinkler M; Petersenn S; Spahn M; Hahner S; Allolio B; J Clin Endocrinol Metab; 2010 Nov; 95(11):4925-32. PubMed ID: 20668036 [TBL] [Abstract][Full Text] [Related]
14. Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma. Gonzalez RJ; Tamm EP; Ng C; Phan AT; Vassilopoulou-Sellin R; Perrier ND; Evans DB; Lee JE Surgery; 2007 Dec; 142(6):867-75; discussion 867-75. PubMed ID: 18063070 [TBL] [Abstract][Full Text] [Related]
15. Is there a role for low doses of mitotane (o,p'-DDD) as adjuvant therapy in adrenocortical carcinoma? Dickstein G; Shechner C; Arad E; Best LA; Nativ O J Clin Endocrinol Metab; 1998 Sep; 83(9):3100-3. PubMed ID: 9745410 [TBL] [Abstract][Full Text] [Related]
16. Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer. Vassilopoulou-Sellin R; Guinee VF; Klein MJ; Taylor SH; Hess KR; Schultz PN; Samaan NA Cancer; 1993 May; 71(10):3119-23. PubMed ID: 8490842 [TBL] [Abstract][Full Text] [Related]
17. Adrenocortical carcinoma: epidemiology and natural history. Boscaro M; Fallo F; Barzon L; Daniele O; Sonino N Minerva Endocrinol; 1995 Mar; 20(1):89-94. PubMed ID: 7651287 [TBL] [Abstract][Full Text] [Related]
18. Adjunctive treatment of adrenocortical carcinoma. Terzolo M; Berruti A Curr Opin Endocrinol Diabetes Obes; 2008 Jun; 15(3):221-6. PubMed ID: 18438168 [TBL] [Abstract][Full Text] [Related]
19. Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer. Berruti A; Fassnacht M; Haak H; Else T; Baudin E; Sperone P; Kroiss M; Kerkhofs T; Williams AR; Ardito A; Leboulleux S; Volante M; Deutschbein T; Feelders R; Ronchi C; Grisanti S; Gelderblom H; Porpiglia F; Papotti M; Hammer GD; Allolio B; Terzolo M Eur Urol; 2014 Apr; 65(4):832-8. PubMed ID: 24268504 [TBL] [Abstract][Full Text] [Related]
20. Systemic treatment of adrenocortical carcinoma in children: data from the German GPOH-MET 97 trial. Redlich A; Boxberger N; Strugala D; Frühwald MC; Leuschner I; Kropf S; Bucsky P; Vorwerk P Klin Padiatr; 2012 Oct; 224(6):366-71. PubMed ID: 23143764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]